APDA, Author at American Parkinson Disease Association

THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE

Posted on September 5, 2019September 4, 2019 by APDA

The American Parkinson Disease Association Awards Fresh Crop of Research Grants & New Diversity-Focused Research Initiative From T cells...see more to genetics, $1.7 million in innovative research to be funded for 2019 – 2020 year NEW YORK, NY – September 5, 2019 – The American Parkinson Disease Association (APDA) has just awarded $1.7 million to support […]

APDA DIVERSITY IN PD RESEARCH GRANT: ACADEMIC YEAR 2022-2023

Posted on September 4, 2019 by APDA

Deadline: 03/11/2022 APPLY HERE Award details One year grant up to a maximum of $75,000 will be awarded to...see more research scientist (MD, MD/PhD, or PhD). The applicants will receive notification of the decision in July 2022. The APDA grant year runs from September 1st to August 31st. Goal APDA Diversity in PD Research Grant is […]

New medication, Istradefylline, gets approved for Parkinson’s disease

Posted on September 4, 2019July 13, 2023 by APDA

On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

APDA Seed Funding Leads to Prestigious NIH Research Grant

Posted on August 16, 2019July 13, 2023 by APDA

APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant.

APDA-funded research finds new role for alpha-synuclein

Posted on July 30, 2019July 13, 2023 by APDA

This new understanding of alpha-synuclein’s function could open up new ways of thinking...see more about treatments for Parkinson's disease.

Merck announces its decision to stop the manufacturing of Sinemet CR

Posted on July 17, 2019July 30, 2019 by APDA

Merck has informed the Food and Drug Administration (FDA)...see more that it will discontinue the manufacturing of Sinemet CR (controlled release).

Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease

Posted on July 15, 2019 by APDA

Bill Rasmussen, founder of ESPN, shares his Parkinson's disease diagnoses.

AMERICAN PARKINSON DISEASE ASSOCIATION CONVENES EXPERTS TO DETERMINE PARKINSON’S DISEASE RESEARCH FUNDING AND TACKLE LACK OF DIVERSITY

Posted on May 21, 2019May 28, 2019 by APDA

APDA Hosts...see more Top Scientists, Researchers and Neurologists for Two Days to Evaluate Research Projects Vying for Funding and Address Lack of Diversity in PD Research & Care NEW YORK, NY, May 21, 2019 – For two days, the […]

Social Media for Good

Posted on May 17, 2019May 28, 2019 by APDA

Facebook and Instagram can be a lot of fun – posting vacation photos, scrolling through...see more images of your friends’ kids and watching adorable puppy videos — but those social media channels can also do a lot of good! Thanks to fundraising tools from Facebook and Instagram, it’s now easier than ever […]